DNANUDGE

DNANUDGE

Nudging your everyday choices through your DNA plus your lifestyle. Buy in-store and online now.

Founded 2015

London, United Kingdom 38 employees Series A Total: $60.00M Health Care

DnaNudge is a UK-based startup founded in 2015, specializing in the Health Care industry. The company's slogan, "Nudging your everyday choices through your DNA plus your lifestyle," encapsulates its mission to leverage genetic insights to influence healthier lifestyle decisions. Led by Regius Professor Chris Toumazou FRS and Dr. Maria Karvela, the startup has pioneered the world's first service to utilize consumers' DNA and lifestyle factors to nudge them towards healthier shopping choices. The recent achievement of DnaNudge is its successful adaptation of the in-store DNA testing service to combat the global obesity and Type 2 diabetes epidemic. This adaptation has taken the form of the rapid, lab-free CovidNudge RT-PCR test, which has gained significant traction amid the current pandemic. The CovidNudge test boasts the capability to accurately detect COVID-19 and other viruses in just over an hour without the need for a laboratory. Notably, this innovation has received a substantial $60.00M Series A investment from Julius Baer Group, Ventura Capital, and Mission Gate on 19 August 2021. As a result, the solution is now undergoing roll-out within the UK's NHS. DnaNudge's dual focus on genetic-driven lifestyle nudges and its agile response to the pressing public health concerns signify its potential to significantly impact the health and wellness landscape. The company's ability to attract notable investment partners underscores the recognition and confidence in its innovative approach.

Funding Stage	Amount	Investors	Lead Investors	Date
Series A	$60.00M	3	Julius Baer Group, Ventura Capital +1	19 Aug 2021

Funding Stage

Amount

Investors

Lead Investors

Date

Series A

$60.00M

Julius Baer Group, Ventura Capital +1

19 Aug 2021

FAQ About DNANUDGE

Nudging your everyday choices through your DNA plus your lifestyle. Buy in-store and online now.

DNANUDGE was founded in 2015.

DNANUDGE is headquartered in London, United Kingdom.

DNANUDGE operates in Health Care. Its work centres on genetics, consumer healthcare, healthtech and wearables. Its customers include Online retail businesses.

DNANUDGE has approximately 38 employees.

DNANUDGE has completed 1 funding round, raising a total of $60.00M. The latest funding stage is Series A.

DNANUDGE offers: E-commerce platform development and maintenance.

Top alternatives and competitors to DNANUDGE include AccurKardia, Forward, Palta, Well Revolution, Aidlab. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

DNANUDGE and AccurKardia are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About DNANUDGE

Services & Products

Target Customers

Funding Rounds & Investors (1)

DNANUDGE Alternatives & Competitors

FAQ About DNANUDGE